GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Santen Pharmaceutical Co 4536.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,894

+0.64%

Close of 6 Nov 2026, in JPY

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥291.62bn

FY2017FY2026

Net income

¥37.37bn

FY2017FY2026

Free cash flow

¥36.66bn

FY2017FY2026

Shareholders' equity

¥296.99bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥291.62bn¥300.00bn¥301.96bn¥279.04bn¥266.26bn¥249.60bn¥241.56bn¥234.03bn¥224.94bn¥199.10bn
Gross profit¥160.97bn¥163.21bn¥163.88bn¥156.57bn¥146.85bn¥140.73bn¥134.70bn¥134.16bn¥129.62bn¥115.76bn
Research and development¥26.18bn¥23.47bn¥24.70bn¥28.30bn¥26.38bn¥24.11bn¥22.68bn¥23.13bn¥23.65bn¥22.08bn
Operating income¥45.57bn¥56.23bn¥51.90bn¥32.02bn¥35.98bn¥37.07bn¥40.13bn¥41.24bn¥38.64bn¥33.30bn
Net income¥37.37bn¥36.26bn¥26.64bn−¥14.95bn¥27.22bn¥9.31bn¥23.62bn¥31.95bn¥35.25bn¥21.72bn
Diluted earnings per share115.84112.0277.36-42.1270.4123.2558.9879.8186.3253.23

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥423.03bn¥409.28bn¥435.70bn¥421.18bn¥459.98bn¥402.35bn¥408.77bn¥391.19bn¥388.46bn¥358.91bn
Cash and short-term investments¥80.88bn¥93.00bn¥94.58bn¥57.90bn¥84.31bn¥63.41bn¥91.43bn¥70.80bn¥69.28bn¥53.63bn
Total liabilities¥127.02bn¥124.10bn¥130.33bn¥127.88bn¥123.13bn¥95.30bn¥106.21bn¥98.61bn¥100.90bn¥102.98bn
Debt¥34.75bn¥33.95bn¥35.16bn¥35.96bn¥35.99bn¥13.05bn¥9.33bn¥4.06bn¥7.60bn¥7.61bn
Shareholders' equity¥296.99bn¥286.24bn¥306.05bn¥293.98bn¥337.49bn¥307.58bn¥302.87bn¥290.90bn¥285.82bn¥255.11bn
Shares outstanding323m324m344m355m387m401m400m400m408m408m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥43.50bn¥60.93bn¥72.65bn¥37.15bn¥46.04bn¥38.81bn¥39.95bn¥32.89bn¥42.84bn¥10.84bn
Capital spending−¥6.84bn−¥6.66bn−¥9.32bn−¥24.59bn−¥35.84bn−¥23.80bn−¥9.23bn−¥5.47bn−¥3.98bn−¥4.14bn
Free cash flow¥36.66bn¥54.27bn¥63.33bn¥12.56bn¥10.20bn¥15.00bn¥30.72bn¥27.42bn¥38.86bn¥6.70bn
Dividends paid−¥12.64bn−¥12.11bn−¥11.88bn−¥12.61bn−¥11.99bn−¥11.19bn−¥10.38bn−¥10.58bn−¥10.56bn−¥10.75bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥68.96bn¥80.86bn¥72.88bn¥69.14bn¥68.74bn¥77.23bn¥76.37bn¥71.63bn
Gross profit¥37.69bn¥49.67bn¥38.54bn¥37.81bn¥34.94bn¥43.72bn¥40.10bn¥38.06bn
Operating income¥8.06bn¥17.07bn¥10.28bn¥10.34bn¥7.53bn¥13.13bn¥11.78bn¥11.78bn
Net income¥7.19bn¥15.54bn¥7.88bn¥8.06bn¥5.88bn¥8.79bn¥8.69bn¥8.14bn
Diluted earnings per share22.3048.1924.3324.9118.1627.1625.2423.63
Cash from operations¥5.26bn¥20.98bn¥8.95bn¥5.85bn¥7.72bn¥18.89bn¥13.73bn¥16.17bn
Capital spending−¥952.0m−¥1.89bn−¥1.56bn−¥1.53bn−¥1.86bn−¥927.0m−¥3.06bn−¥2.10bn
Free cash flow¥4.31bn¥19.09bn¥7.38bn¥4.32bn¥5.86bn¥17.96bn¥10.67bn¥14.06bn
Total assets¥415.85bn¥423.03bn¥401.16bn¥389.14bn¥408.12bn¥409.28bn¥398.31bn¥409.08bn
Cash and short-term investments¥78.26bn¥80.88bn¥61.54bn¥63.56bn¥84.58bn¥93.00bn¥77.85bn¥84.44bn
Debt—¥3.53bn———¥3.02bn——
Shareholders' equity¥300.26bn¥296.99bn¥283.38bn¥274.77bn¥281.26bn¥286.24bn¥284.03bn¥288.98bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.5%3.2%4.1%
Operating income12.5%4.2%2.2%
Net income—32.0%-3.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin54.8%55.0%55.2%56.1%
Operating margin17.2%15.8%15.3%16.1%
Net margin12.4%7.3%7.2%10.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings16.314.520.9-33.415.360.528.426.118.433.3
Price to sales2.11.81.91.81.62.32.83.62.93.6

Dividends and splits

Per share, in the currency the company pays

Paid for 36 years. Last went ex-dividend on 29 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year21.0057.0034.0032.0032.0030.0028.0026.00
  • 5-for-1 split · 27 Mar 2015
  • 1.1-for-1 split · 26 Mar 1997
  • 1.1-for-1 split · 26 Mar 1996
  • 1.1-for-1 split · 28 Mar 1995
  • 1.1-for-1 split · 28 Mar 1994
  • 1.1-for-1 split · 26 Mar 1993

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.